Biotechnology stocks

Stephen Hoffman as CEO of Alios raised about 40 million of private funding before he and the current CEO, Michael Hart, did a tremendous job of taking the company public and raising 90 million. The public offering just made the window by a few dozen hours for an IPO, as the window quickly closed after President Clinton announced that the human genome sequence could not be patented. This news sent the biotechnology stock market plummeting. 

The standard stocks of the positive and negative serum were obtained from the State Research Institute of Biotechnology and Strains of Microorganisms Control of the Ministry of Agroindustrial Policy of Ukraine as well as from the National Reference Laboratory for EBI (Federal Research Institute for Animal Health, Germany). 

Protein phosphatase 2A (PP2A) (Upstate Biotechnology, USA) the activity of the stock solution is 1900 U mL 1, 1 unit being defined as the amount of enzyme required to hydrolyse 1 nmol of p-nitrophe-nyl phosphate (p-NPP) in 1 min at room temperature. 

A third trend is towards the search for cheap feed stock sources. This development started quite a while ago. Methanol used as a carbon source for microbial growth is of real interest at present. Cellulose and hemicellulose as components of wood are not yet an economic alternative, but recent progress is very impressing. It can easily be foreseen that wood will be utilized as a new resource for biotechnology within the next 10 years. 

There are currently two known stocks of the virus, one at the U.S. Center for Disease Control and Prevention in Atlanta and the other at the State Research Center of Virology and Biotechnology in Koltsovo, Russia. It is widely known that from 1980 until the mid-1990s researchers in the Soviet Union developed a highly virulent strain of Variola major for use as a biological weapon, with a significantly reduced incubation period (Henderson and Fenner 2001). 

The NASBAprimer stocks (Operon Biotechnologies, Alameda, CA) are diluted to lOOpM with RNAse free water. 

B. Atkinson, F. Mavituna, Biochemical Engineering and Biotechnology Handbook, Stock-ton Press, New York, 1991... 

There are more than 4000 biotech-oriented companies around the world, approximately 600 of which are hsted on the stock exchange. The number of marketed dmgs manufactured by means of biotechnology is steadily increasing. Actually, in 2004, approximately 370 medicinal products were in advanced (phase II and III) chnical development. 

The recombinant DNA technology of Cohen and Boyer enabled them to generate the first commercial product in 1978 human insulin expressed in Escherichia coli. These efforts also led to the first biotech company on 15 October 1980 Genen-tech went public on the New York Stock Exchange. Fascination about this modern biopharmaceutical and the huge potential of the new biotechnology caused the stock price to jump from US 35 to 89 in the first 20 minutes by the evening of the same day, the market capitalization was US 66 million ... 

Roberto P. Stock, Alejandro Olvera, Ricardo Sanchez, Andreas Saralegui, Sonia Scarfi, Rosana Sanchez-Lopez, Marco A. Ramos, Lidia C. Boffa, Umberto Benatd, Alejandro Alagon, Inhibition of gene expression in Entamoeba histolytica with antisense peptide nucleic acid oligomers. Nature Biotechnology, 19 (2001), 231-234. 

FacklamT J, Geyer S. The preparation and validation of stock cultures of mammalian cells. In Y H Chui, J L Gueriguian (eds.). Drug Biotechnology Regulation Scientific Basis and Practices. Marcel Dekker, Inc., New York, 1991, pp. 54-85. 

---